Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
about
Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysisRescue Therapy with a Proton Pump Inhibitor Plus Amoxicillin and Rifabutin for Helicobacter pylori Infection: A Systematic Review and Meta-AnalysisCancer prevention and control: alarming challenges in ChinaEfficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection'Rescue' therapies for the management of Helicobacter pylori infection.Treatment of Helicobacter pylori infection.Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication.Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review.Second-line rescue therapy of helicobacter pylori infection.American College of Gastroenterology guideline on the management of Helicobacter pylori infection.Rifabutin-based high-dose proton-pump inhibitor and amoxicillin triple regimen as the rescue treatment for Helicobacter pyloriComparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori.Efficacy of microencapsulated lactic acid bacteria in Helicobater pylori eradication therapy.Eradication of Helicobacter pylori: recent advances in treatment.Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection.Effectiveness of antiinfectives.Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.Effective regimens for the treatment of Helicobacter pylori infection.Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic.Nitrofuran-based regimens for the eradication of Helicobacter pylori infection.Effectiveness of Second through Sixth Line Salvage Helicobacter pylori Treatment: Bismuth Quadruple Therapy is Almost Always a Reasonable Choice."Rescue" regimens after Helicobacter pylori treatment failure.Helicobacter pylori: testing and treatment.Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer diseaseHelicobacter pylori eradication therapy.Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.Therapeutic management of recurrent peptic ulcer disease.Emerging therapies for the treatment of Helicobacter pylori infections.Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.Comparison of levofloxacin versus clarithromycin efficacy in the eradication of Helicobacter pylori infection.Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies.Third-line rescue therapy for Helicobacter pylori infection.How effective are rescue H. pylori eradication therapies in patients with dyspepsia?Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
P2860
Q26823010-F526FD89-8736-4FD6-B257-DB944347CE22Q28085359-C333B166-8A7A-4FCF-8A8A-F3B112A51E9AQ28396786-2902F0EA-B2EA-4FF5-970A-FE3017AB1D14Q33291670-E83E0D36-F013-40E6-B0F4-5C85E947C766Q33371187-13528BD9-0B69-486E-8CAD-27F2A3A1DCE9Q33372344-65BB1FB8-F698-4365-817B-B815D61BCD4AQ33452908-AA7B3FED-E4DC-4253-9B5B-4150B68A859AQ34404967-88891953-FC74-4DED-9091-E24B029165C5Q34409114-7FC9842B-91E0-4DFE-86AE-EF3BB171F98CQ34645482-ED1D0A82-D6E1-4DFA-944B-CF9E9CCF8FA0Q34823645-98FB3888-A71C-4AB4-A2B6-0016AA112D92Q35765342-2DECB3DE-9289-49F9-B031-797663C03BE7Q35940597-2805B0EF-8D2B-450B-8F1C-BBD21E356994Q36191284-AC7C2BB6-D782-45ED-9C29-CE29376F3C2EQ36214570-EB831800-57D5-4933-8058-8F35517D2873Q36222718-A13DE927-F727-472B-B10E-5283DB8FB27CQ36322095-A9E25976-89CF-47FC-AB1E-829213398218Q36568724-71FBA8E4-03BA-46BE-BADF-66D8C6F0EF5EQ36723844-112CF286-D5CE-4101-BFC3-40C10E3BBBEFQ36936445-A25F93BB-0B5B-4F59-9AD9-242C43DDED8BQ36997005-EB8E5C0A-715C-4825-BA24-828DFB5E5691Q37273653-49B1B0E3-0330-4B20-A799-52CB0F49266CQ37346038-BEA3126D-39DE-45D3-ABFD-A08D2D23E276Q37386612-464D9BF7-05FC-40D3-BF96-B99CFD2450FEQ37721423-EFD7F34D-6EBA-4115-BF18-FC30AEEC0008Q37963008-8640E8E5-332E-4C8B-9BA0-222A3BEF0B21Q38032319-E94A0735-4C13-43C8-8339-60BBEA8A7773Q38424698-C899F61B-5CEE-43A8-8E2D-E7E961F1E882Q40294669-918B7CF0-EF51-448A-87E7-ED9B6A9AE99EQ40378087-2FFB9122-F322-4904-A551-0B2EE21ABFD6Q40401286-2C887283-6699-4CBB-9FB3-1CC47A3CCC4BQ40819420-8A0D7AFA-FB74-4FA3-8E42-E43ED0259D63Q42726333-B24619E5-733D-4F93-9AC4-A0A50AEF91D8Q46787142-F33D6B09-2DE8-4D99-83EB-6274D8F7C625Q46915097-D6B293A1-4AF3-4A34-A5C7-EA7286A05C92Q54592157-96FB89DC-F6CE-465B-8A72-F53A35C9FDB6
P2860
Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Rifabutin- and furazolidone-ba ...... ttempts in dyspepsia patients.
@en
Rifabutin- and furazolidone-ba ...... ttempts in dyspepsia patients.
@nl
type
label
Rifabutin- and furazolidone-ba ...... ttempts in dyspepsia patients.
@en
Rifabutin- and furazolidone-ba ...... ttempts in dyspepsia patients.
@nl
prefLabel
Rifabutin- and furazolidone-ba ...... ttempts in dyspepsia patients.
@en
Rifabutin- and furazolidone-ba ...... ttempts in dyspepsia patients.
@nl
P2093
P2860
P1476
Rifabutin- and furazolidone-ba ...... ttempts in dyspepsia patients.
@en
P2093
Asghar Qasim
Colm O'Morain
Humphrey O'Connor
Mark Dobson
Martin Buckley
Orla Thornton
Ramona McLoughlin
Shaji Sebastian
P2860
P356
10.1111/J.1365-2036.2004.02210.X
P407
P577
2005-01-01T00:00:00Z